藥物交互作用
Bazedoxifene-conjugated estrogens + Somapacitan
嚴重程度: 中度
Bazedoxifene-conjugated estrogens and Somapacitan: moderate interaction.
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
摘要
Oral estrogens reduce hepatic IGF-1 production in response to growth hormone, so patients taking somapacitan may have a blunted IGF-1 response. Higher somapacitan doses may be needed when oral estrogen is started, and dose reduction may be needed if it is stopped.
用白話說明這項交互作用的意義
Bazedoxifene-conjugated estrogens and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bazedoxifene-conjugated estrogens belongs to Endocrine; Somapacitan belongs to Endocrine.
為什麼會發生
First-pass hepatic exposure to oral estrogen suppresses growth hormone-induced IGF-1 generation in the liver.
處置方式
Monitor serum IGF-1 and clinical response, and titrate the somapacitan dose when starting or stopping the estrogen. Consider a non-oral estrogen route if clinically appropriate.
可向藥師詢問的問題
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Bazedoxifene-conjugated estrogens 的其他交互作用
- Anastrozole + Bazedoxifene-conjugated estrogens 禁忌併用
- Bazedoxifene-conjugated estrogens + Ospemifene 禁忌併用
- Antithrombin alfa + Bazedoxifene-conjugated estrogens 嚴重
- Antithrombin iii + Bazedoxifene-conjugated estrogens 嚴重
- Bazedoxifene-conjugated estrogens + Bemiparin 嚴重
- Bazedoxifene-conjugated estrogens + Carbamazepine 嚴重
Somapacitan 的其他交互作用
常見問題
Can I take Bazedoxifene-conjugated estrogens with Somapacitan?
MediHelp rates the interaction as moderate. Bazedoxifene-conjugated estrogens and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oral estrogens reduce hepatic IGF-1 production in response to growth hormone, so patients taking somapacitan may have a blunted IGF-1 response. Higher somapacitan doses may be needed when oral estrogen is started, and dose reduction may be needed if it is stopped.
How serious is the interaction between Bazedoxifene-conjugated estrogens and Somapacitan?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum IGF-1 and clinical response, and titrate the somapacitan dose when starting or stopping the estrogen. Consider a non-oral estrogen route if clinically appropriate.
What other medicines interact with Bazedoxifene-conjugated estrogens?
MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
